Almac is uniquely positioned with a dedicated Biostatistics Group who are 100% focused on Randomisation and IXRS® Implementation / Support. The Biostatistics Group is comprised of experienced Biostatisticians and Biostatistics Data Managers.
Almac’s Biostatistics group offers randomisation consultancy upfront and across the study’s lifecycle:
• Regulatory considerations of randomisation
• Evaluation of blinding / potential for selection-bias
• Selection of randomisation methodology and parameterisation
• Treatment balance impact
• IXRS® randomisation solutions for any type of study (from simple to complex)
